Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are pregnant

This page signposts to current guidance on this off-label use of the two medicines from the UK Royal College of Obstetricians and Gynaecologists and UKTIS. Healthcare professionals are encouraged to contact UKTIS should they be considered for use.

SPS commentary:

A page containing advice on the use of tocilizumab or sarilumab for hospitalised patients with COVID-19 who are breastfeeding is also available.

Specialist Pharmacy Service

Resource links:

Using Tocilizumab or Sarilumab for hospitalised patients with COVID-19 who are breastfeeding